the compounding thing finally clicked for me and I want to write it down
Posting this as a discussion rather than a claim: the compounding thing finally clicked for me and I want to write it down. Why "compounded" is not "generic", written out because the confusion is constant. A generic is an approved product demonstrated to be bioequivalent to a reference. A compounded preparation is…
A beyond-use date derived from published stability data means something different from one assigned by default rule. Asking which is a fair question and the answer is usually available.
Asked which facility and got a name straight away. Looked it up, found the registration, felt considerably better about the whole thing.
Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.
Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.
shortage status changes and the whole arrangement changes with it
Yes. The shortage list is the legal hinge for the whole arrangement and its status is public.
the pharmacy and the prescriber are two separate questions
the shortage list is the whole legal hinge and people skip it
Removed the staff name. Facilities and clinics can be named here; individuals cannot.
a 503B has to register and report, so there is a paper trail to ask for
Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.
compounded is not generic, there is no equivalence claim
503A or 503B — do you know which?